RN7SL378P

Across TCGA pan-cancer cohorts, RN7SL378P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RN7SL378P data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher RN7SL378P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL378P expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

DLBC, HNSC, and UVM are the cancer types where RN7SL378P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	All	0.479	0.857	<.001	66	view →
HNSC	OS	Tertile	IV	0.724	0.360	.010	66	view →
UVM	OS	Tertile	All	0.136	0.919	<.001	45	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
LUSC	OS	Tertile	IV	0.057	0.786	.008	36	view →
KIRP	DFS	Tertile	All	0.348	0.834	.001	36	view →
READ	DFS	Tertile	All	0.207	0.765	<.001	30	view →
ACC	DFS	Tertile	III,IV	0.046	0.670	.001	27	view →
SKCM	DFS	Tertile	III,IV	0.344	0.316	.015	18	view →
LUAD	DFS	Tertile	All	0.933	0.794	.017	18	view →
LAML	DFS	Tertile	All	0.732	0.409	.013	12	view →
PAAD	DFS	Tertile	All	0.335	0.532	.047	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RN7SL378P–DLBC (DFS)

Open the DLBC breakdown →